WINTON GROUP Ltd Buys Shares of 35,602 Humana Inc. $HUM

WINTON GROUP Ltd purchased a new position in shares of Humana Inc. (NYSE:HUMFree Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 35,602 shares of the insurance provider’s stock, valued at approximately $14,142,000.

Several other institutional investors and hedge funds also recently made changes to their positions in HUM. Johnson Financial Group Inc. acquired a new stake in Humana during the 2nd quarter worth approximately $26,000. Trust Co. of Vermont acquired a new position in Humana in the 2nd quarter valued at approximately $28,000. Bogart Wealth LLC raised its stake in shares of Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after acquiring an additional 48 shares during the last quarter. MidFirst Bank bought a new position in shares of Humana during the second quarter valued at $35,000. Finally, Fideuram Asset Management Ireland dac acquired a new position in shares of Humana during the fourth quarter worth $27,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Price Performance

HUM stock opened at $401.06 on Thursday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The firm has a market cap of $48.16 billion, a price-to-earnings ratio of 37.94, a PEG ratio of 2.64 and a beta of 0.74. The company’s fifty day simple moving average is $388.61 and its 200 day simple moving average is $301.31. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88.

Humana (NYSE:HUMGet Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same period last year, the business posted $6.27 EPS. The business’s revenue was up 26.2% compared to the same quarter last year. On average, analysts expect that Humana Inc. will post 9 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 annualized dividend and a yield of 0.9%. Humana’s dividend payout ratio (DPR) is currently 33.49%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on HUM shares. Raymond James Financial downgraded Humana from an “outperform” rating to a “market perform” rating in a report on Thursday, July 30th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $425.00 target price on shares of Humana in a report on Wednesday, June 3rd. Guggenheim upped their price target on Humana from $269.00 to $471.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. Morgan Stanley raised Humana from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $249.00 to $370.00 in a research note on Tuesday, August 4th. Finally, Truist Financial lifted their price objective on Humana from $320.00 to $415.00 and gave the stock a “hold” rating in a research note on Tuesday, July 14th. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average price target of $403.91.

Check Out Our Latest Research Report on Humana

Humana Profile

(Free Report)

Humana Inc (NYSE:HUM) is a U.S.-based health insurance and health care services company focused primarily on government-sponsored programs. Its offerings include Medicare Advantage plans, Medicare prescription drug plans, Medicaid coverage and specialty insurance products, serving individuals, employers and government organizations.

Through its CenterWell business, Humana also provides senior-focused primary care, pharmacy services and home health care. These operations are designed to support coordinated care for older adults and other members with ongoing health care needs.

Humana was founded in 1961 as a nursing-home company and later expanded into hospital ownership before shifting its focus toward health insurance.

Recommended Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.